These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25797367)

  • 1. Web-based intensive monitoring of adverse events following influenza vaccination in general practice.
    van Balveren-Slingerland L; Kant A; Härmark L
    Vaccine; 2015 May; 33(19):2283-2288. PubMed ID: 25797367
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination.
    Kemmeren J; Honsbeek M; Dijkstra F; de Lange M; van der Maas N; Smallenburg R; Koppeschaar C; van der Hoek W
    Vaccine; 2016 Jul; 34(34):3961-6. PubMed ID: 27349839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.
    Härmark L; van Hunsel F; Hak E; van Grootheest K
    Vaccine; 2011 Feb; 29(10):1941-7. PubMed ID: 21236235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination.
    Wilson K; Atkinson KM; Westeinde J; Bell C; Marty K; Fergusson D; Deeks SL; Crowcroft N; Bettinger JA
    Hum Vaccin Immunother; 2016 Jul; 12(7):1738-48. PubMed ID: 26905396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccination in healthcare workers; comparison of side effects and preferred route of administration of intradermal versus intramuscular administration.
    Meijer WJ; Wensing AMJ; Bos AA; Kuiphuis JCF; Hagelen EMM; Wilschut JC; de Vries MJT; Riezebos-Brilman A
    Vaccine; 2017 Mar; 35(11):1517-1523. PubMed ID: 28196736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase.
    Carnovale C; Raschi E; Leonardi L; Moretti U; De Ponti F; Gentili M; Pozzi M; Clementi E; Poluzzi E; Radice S
    Expert Rev Vaccines; 2018 Apr; 17(4):363-381. PubMed ID: 29452497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands.
    van Puijenbroek EP; Broos N; van Grootheest K
    Drug Saf; 2010 Dec; 33(12):1097-108. PubMed ID: 21077700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events.
    Dey A; Gidding HF; Menzies R; McIntyre P
    Vaccine; 2014 Apr; 32(19):2204-8. PubMed ID: 24613527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring adverse events of vaccines against Mexican flu.
    van Puijenbroek EP; van Grootheest AC
    Int J Risk Saf Med; 2011; 23(2):81-7. PubMed ID: 21673415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine safety.
    Labadie J
    Int J Risk Saf Med; 2011; 23(2):113-5. PubMed ID: 21673419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reported adverse events following influenza vaccination].
    van Balveren-Slingerland L; Rümke HC; Kant AC
    Ned Tijdschr Geneeskd; 2014; 158():A6841. PubMed ID: 24518843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of seizures among adults and children following influenza vaccination using health insurance claims data.
    Thyagarajan V; Su S; Gee J; Duffy J; McCarthy NL; Chan KA; Weintraub ES; Lin ND
    Vaccine; 2013 Dec; 31(50):5997-6002. PubMed ID: 24148576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a cohort for deep phenotyping of the immune response to influenza vaccination among elderly individuals recruited from the general population.
    Akmatov MK; Riese P; May M; Jentsch L; Ahmed MW; Werner D; Rösel A; Tyler M; Pessler K; Prokein J; Bernemann I; Klopp N; Prochnow B; Trittel S; Tallam A; Illig T; Schindler C; Guzmán CA; Pessler F
    Hum Vaccin Immunother; 2017 Jul; 13(7):1630-1639. PubMed ID: 28394705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.
    Clothier HJ; Crawford N; Russell MA; Buttery JP
    Euro Surveill; 2017 May; 22(20):. PubMed ID: 28552101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A/H1N1 pandemic influenza vaccination: A retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy.
    Fabiani M; Bella A; Rota MC; Clagnan E; Gallo T; D'Amato M; Pezzotti P; Ferrara L; Demicheli V; Martinelli D; Prato R; Rizzo C
    Vaccine; 2015 May; 33(19):2240-2247. PubMed ID: 25820060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16.
    Bricout H; Chabanon AL; Souverain A; Sadorge C; Vesikari T; Caroe TD
    Euro Surveill; 2017 May; 22(18):. PubMed ID: 28494843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010.
    Parrella A; Gold M; Marshall H; Braunack-Mayer A; Watson M; Baghurst P
    Hum Vaccin Immunother; 2012 May; 8(5):662-7. PubMed ID: 22634441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
    Halsey NA; Griffioen M; Dreskin SC; Dekker CL; Wood R; Sharma D; Jones JF; LaRussa PS; Garner J; Berger M; Proveaux T; Vellozzi C; ; Broder K; Setse R; Pahud B; Hrncir D; Choi H; Sparks R; Williams SE; Engler RJ; Gidudu J; Baxter R; Klein N; Edwards K; Cano M; Kelso JM
    Vaccine; 2013 Dec; 31(51):6107-12. PubMed ID: 24120547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands.
    Slingerland P; van Hunsel FPAM; Lieber T; van Balveren L; Duijster JW
    Drug Saf; 2023 Dec; 46(12):1323-1334. PubMed ID: 37882905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid assessment of the reactogenicity of a 2016-2017 seasonal influenza vaccine: results from a feasibility study.
    Stuurman AL; Verstraeten T; De Schryver A
    Expert Rev Vaccines; 2017 Feb; 16(2):187-191. PubMed ID: 27882801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.